Affiliation: Merck Research Laboratories
- Antihypertensive drug therapy in Saskatchewan: patterns of use and determinants in hypertensionC Bourgault
Department of Epidemiology and Biostastics, Royal Victoria Hospital, McGill University Health Centre (MUHC, 687 Pine Ave W, Ross 4.29, Montreal, Quebec, Canada H3A 1A1
Arch Intern Med 161:1873-9. 2001..In addition, initial drug use does not seem to be in accordance with the stepped-care approach to hypertension therapy recommended in the Canadian guidelines...
- Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based studyC Bourgault
Health Economics and Outcomes Research, Merck Frosst Canada Ltd, 16 711 TransCanada Highway, Kirkland, Quebec, Canada H9H 3L1
J Hum Hypertens 19:607-13. 2005..Further studies are required that relate intermittent treatment behaviours to health outcomes and costs in hypertension...
- Statin therapy in Canadian patients with hypercholesterolemia: the Canadian Lipid Study -- Observational (CALIPSO)C Bourgault
McGill University, Montreal, Canada
Can J Cardiol 21:1187-93. 2005..Although statins are widely used to reduce low density lipoprotein cholesterol (LDL-C), there is little information about patient profiles, treatment patterns and goal achievement among statin-treated patients in Canada...
- Antihypertensives and myocardial infarction risk: the modifying effect of history of drug useC Bourgault
Department of Epidemiology and Biostatistics, McGill University, Montreal, Canada
Pharmacoepidemiol Drug Saf 10:287-94. 2001..In addition, the estimates significantly varied across drug history profiles thus suggesting the presence of preferential prescribing of specific drug classes to high-risk patients...